Skip to content

13F-HR/A filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR/A for the quarter ended 2018-09-30, filed 2018-11-15, with 31 holding rows worth $637,804,000.

Accession
0001567619-18-006412
Filed
2018-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, amendment of type restatement, 31 entries on the cover page, a total value of $637,804,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $637,804,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Abbott Laboratories002824100COM982,312$72,062,000thousands by filing date
BAXTER INTL INC071813109COM706,228$54,443,000thousands by filing date
Boston Scientific Corporation101137107COM1,383,374$53,260,000thousands by filing date
Merck & Co.,Inc.58933Y105COM731,046$51,860,000thousands by filing date
Bristol-Myers Squibb Company110122108COM720,880$44,752,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO205,256$37,207,000thousands by filing date
REVVITY INC714046109COM369,081$35,901,000thousands by filing date
BIO RAD LABS INC090572207CL A96,697$30,265,000thousands by filing date
NUVASIVE INC670704105COM395,223$28,053,000thousands by filing date
Gilead Sciences,Inc.375558103COM323,187$24,953,000thousands by filing date
Elevance Health, Inc.036752103COM83,513$22,887,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW338,733$22,312,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock313,220$22,176,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock213,300$15,046,000thousands by filing date
INCYTE CORP COM45337C102Stock213,764$14,767,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock105,012$13,425,000thousands by filing date
BIOGEN INC COM09062X103Stock36,000$12,719,000thousands by filing date
PATTERSON COS INC703395103COM477,707$11,680,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock202,434$10,442,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK862,602$9,204,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM136,335$7,362,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR182,905$7,238,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock269,701$7,182,000thousands by filing date
DR REDDYS LABS LTD ADR256135203ADR171,219$5,924,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM185,577$5,450,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock334,100$5,078,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock45,437$3,977,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM154,960$2,627,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM29,368$2,242,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM33,814$1,845,000thousands by filing date
Eli Lilly and Company532457108COM13,650$1,465,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-18-005343 superseded2018-11-08acceptance time not in the bulk data set
13F-HR/A 0001567619-18-006412this filing2018-11-15acceptance time not in the bulk data set